Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

882
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
882
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

673
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
673
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

606
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
606
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

747
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
747
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

624
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
624

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps.

Journal of human hypertension·2026
Same author

Healthcare insurance status and hypertension control before and after the Affordable Care Act.

American journal of hypertension·2026
Same author

Pizza and Paintballs: A Cost-Effective Model for Incision and Drainage Simulation Training.

Journal of education & teaching in emergency medicine·2025
Same author

Predicted Cardiovascular and Economic Impacts of the Measure Accurately, Act Rapidly, and Partner With Patients Program to Improve Hypertension Control.

American journal of preventive medicine·2025
Same author

Height May Explain Sex Differences in Systolic Blood Pressure in Older Adults.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Non-debatable issues in defining blood pressure targets for hypertension - Editorial.

Blood pressure·2025

Related Experiment Video

Updated: Apr 22, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

831

Antihypertensive medication persistence 1-year post-stroke hospitalization.

Andrea D Boan1, Brent M Egan, David L Bachman

  • 1Department of Pediatrics, Medical University of South Carolina, Charleston, SC; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC.

Journal of Clinical Hypertension (Greenwich, Conn.)
|October 14, 2014
PubMed
Summary

Long-term use of blood pressure medications after stroke is crucial for preventing recurrence. However, persistence on all prescribed drugs, especially among Black patients and those with many health issues, remains low.

Related Experiment Videos

Last Updated: Apr 22, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

831

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Antihypertensive treatment significantly reduces recurrent stroke risk.
  • Translating this evidence into clinical practice requires understanding long-term medication adherence post-stroke.

Purpose of the Study:

  • To assess the frequency of long-term antihypertensive drug persistence 1-year after stroke hospitalization.
  • To identify factors associated with low persistence in stroke survivors.

Main Methods:

  • Structured telephone interviews were used to determine antihypertensive regimen persistence.
  • 270 stroke survivors were assessed, with 212 discharged on antihypertensive therapy.

Main Results:

  • Overall persistence on any antihypertensive agent was high (87.3%) at 1 year.
  • Persistence on all or multiple drug classes was low (38.7%).
  • Black patients and those with high comorbidity burden showed lower persistence.

Conclusions:

  • While overall use is high, maintaining complex antihypertensive regimens post-stroke is challenging.
  • Racial disparities and comorbidity burden impact medication persistence.
  • Further research is needed to optimize therapy and address disparities in secondary stroke prevention.